Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. EQT – sale of Com Hem
Mandate

EQT – sale of Com Hem

July 19, 2006

EQT has signed an agreement with Carlyle Group and Providence Equity Partners for the sale of Com Hem. The acquisition provides Carlyle Group and Providence Equity good conditions for growth and also creates a good platform for future business in the Swedish and Norwegian market. The sale of Com hem is estimated to be worth approximately EUR 1 billion.

Vinge represented EQT and representatives from Vinge included Frederik von Baumgarten, Mattias Schömer, Olle Rislund, Peter Forsberg, David Aversten, Niclas Bergström and Anna Möller.

Related

Vinge advises SAGA Diagnostics AB on convertible note issue

 SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

 Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023

Vinge has advised private equity firm Stirling Square Capital Partners

 Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023